Supplementary Figures from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

Abstract

Supplementary Figures - PDF file 441K, Four figures as follows: SF1: decreased PTEN expression in HNSCC with PTEN loss. SFs 2-4: PIK3CA mutant HNSCC tumorgrafts treatment response characterization; PI3K inhibitors +/- cetuximab, tumor measurements and western blotting for PI3K signaling</p